BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 17/09/2021

FDA Announces Revised Draft Guidances for Ferric Oxyhydroxide Industry

The FDA has released revised draft guidances for industry, providing product-specific recommendations for ferric oxyhydroxide oral tablets and intravenous injectable, to support abbreviated new drug applications.

Source: Federal Register — Food and Drug AdministrationOpen original release →